XABT Successfully Developed SARS-CoV-2 Lineage B.1.1.7 Detection Kit!

The SARS-CoV-2 lineage B.1.1.7, now designated Variant of Concern 202012/01 (VOC) by Public Health England, originated in the UK in late Summer to early Autumn 2020.   On January 2, 2021, following S

DECLARATION OF CONFORMITY——XABT Supplies PCR Kit for Detection of 2019-nCoV to the EU Market

On February 27, 2020, Beijing Applied Biological Technologies Co., Ltd. and the Institute of Pathogen Biology of the Chinese Academy of Medical Sciences jointly developed 2019-nCoV nucleic acid detec

The Mayor of Lima, the Republic of Peru, thanks XABT for the kind contributions to help fight pande

After the outbreak of pandemic in South America, XABT donated 5,040 Multiple Real Time PCR Kits for Detection of 2019-nCOV and related supporting materials to Lima, Peru under the frameword of Beijin

XABT Is Officially Included in the WHO Emergency Use List (EUL)!

XABT 2019-nCoV nucleic acid detection kit (fluorescence PCR method) was officially listed as the World Health Organization (referred to as "WHO") Emergency Use Listing (referred to as "EUL").  Availa

XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Italy

On March 19, the 2019-nCoV Detection Kit and Nucleic Acid Extraction Donation & Shipment Ceremony was held in Beijing. Beijing Applied Biological Technolog